Human Immunodeficiency Virus (HIV) and endodontics: a review

Bürklein, Sebastian; Schäfer, Edgar
March 2007
Endodontic Practice Today;2007, Vol. 1 Issue 1, p37
Academic Journal
Due to the introduction of highly active antiretroviral therapy (HAART), HIV infection has gradually become more of a chronic immunodeficiency disease. In response to HAART, the CD4 cell count, in most cases, increases and thereby the HIV-infected patients are at a lower risk of developing opportunistic infections; this leads to an enhanced quality of life and a reduced mortality. Therefore, nowadays, the endodontist is more likely to encounter an HIV-infected patient in need of endodontic treatment. Unfortunately there is a lack of guidelines for the treatment of HIV-infected or AIDS patients. The intention of this overview is to evaluate current knowledge regarding endodontic treatment and its outcome in HIV-infected patients.


Related Articles

  • The Epidemiology of Intestinal Microsporidiosis in Patients with HIV/AIDS in Lima, Peru. Bern, Caryn; Kawai, Vivian; Vargas, Daniel; Rabke-Verani, Jennifer; Williamson, John; Raul Chavez-Valdez; Xiao, Lihua; Sulaiman, Irshad; Vivar, Aldo; Ticona, Eduardo; Ñavincopa, Marco; Cama, Vitaliano; Moura, Hercules; Secor, W. Evan; Visvesvara, Govindor; Gilman, Robert H. // Journal of Infectious Diseases;5/15/2005, Vol. 191 Issue 10, p1658 

    We studied microsporidiosis in human immunodeficiency virus-positive patients in 2 Lima hospitals. Of 2652 patients, 66% were male, 6% received antiretroviral therapy (ART), and the median CD4 lymphocyte count was 131 cells/μL. Sixty-seven patients (3%) had microsporidiosis; stool specimens...

  • Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database. Srasuebkul, Preeyaporn; Poh Lian Lim; Man Po Lee; Kumarasamy, Nagalingeswaran; Jialun Zhou; Sirisanthana, Thira; Li, Patrick C. K.; Kamarulzaman, Adeeba; Oka, Shinichi; Phanuphak, Praphan; Vonthanak, Saphonn; Merati, Tuti P.; Chen, Yi-Ming A.; Sungkanuparph, Somnuek; Goa Tau; Fujie Zhang; Lee, Christopher K. C.; Ditangco, Rossana; Pujari, Sanjay; Choi, Jun Y. // Clinical Infectious Diseases;4/1/2009, Vol. 48 Issue 7, p940 

    Objective. The aim of our study was to develop, on the basis of simple clinical data, predictive short-term risk equations for AIDS or death in Asian patients infected with human immunodeficiency virus (HIV) who were included in the TREAT Asia HIV Observational Database. Methods. Inclusion...

  • Risco cardiovascular em doentes infectados por Vírus da Imunodeficiência Humana. Valadas, E.; Sousa, S.; Antunes, F. // RPDI - Revista Portuguesa de Doenças Infecciosas;jan-abr2009, Vol. 5 Issue 1, p07 

    Introduction: Human immunodeficiency virus (HIV) infection, as well as some antiretroviral drugs, has been described to aggravate classical risk factors for cardiovascular disease. Objective: To quantify the cardiovascular risk (CVR) in HIV infected individuals, and to determine the prevalence...

  • Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy. El-Sadr, W. M.; Cohen, C. J.; Emery, S.; Lundgren, J. D.; Grund, B.; Neuhaus, J.; Phillips, A.; Neaton, J. D.; Babiker, A.; Darbyshire, J. // Annals of Internal Medicine;9/2/2008, Vol. 149 Issue 5, p289 

    Background: Episodic use of antiretroviral therapy guided by CD4+ cell counts is inferior to continuous antiretroviral therapy. Objective: To determine whether reinitiating continuous antiretroviral therapy in patients who received episodic treatment reduces excess risk for opportunistic disease...

  • NeuroAIDS: An Evolving Epidemic. Power, Christopher; Boissé, Lysa; Rourke, Sean; Gill, M. John // Canadian Journal of Neurological Sciences;May2009, Vol. 36 Issue 3, p285 

    Over 60,000 Canadians are infected with human immunodeficiency virus (HIV). Greater than 50% of these individuals will develop a neurological disorder despite the availability of highly active antiretroviral therapy. HIV causes nervous system disease at all stages of infection with adverse...

  • The increasing chronicity of HIV in sub-Saharan Africa: Re-thinking "HIV as a long-wave event" in the era of widespread access to ART.  // Globalization & Health;2011, Vol. 7 Issue 1, p41 

    The article discusses the conceptualization of HIV pandemic as a chronic disease, following the wide accessibility of antiretroviral therapy (ART). It states that in 1990s HIV was described as a 'long-wave event,' involving three curves: HIV curve, AIDS curve, and a curve depicting societal...

  • Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/μL. Manosuthi, Weerawat; Sungkanuparph, Somnuek; Tansuphaswadikul, Somsit; Inthong, Yaowarat; Prasithsirikul, Wisit; Chottanapund, Suthat; Mankatitham, Wiroj; Chimsuntorn, Sukanya; Sittibusaya, Chayanan; Moolasart, Visal; Chumpathat, Nopphanath; Termvises, Patamavadee; Chaovavanich, Achara // International Journal of STD & AIDS;Nov2007, Vol. 18 Issue 11, p782 

    The objective of the study was to determine cumulative incidence and risk factors of nevirapine (NVP)-associated rashes that lead to NVP discontinuation among HIV-infected patients with CD4 <250 cells/μL. A retrospective cohort study was conducted among antiretroviral-naïve HIV-infected...

  • Eight strategies to trim transmission risk in people with HIV. Mascolini, Mark // Research Initiative/Treatment Action!;Winter2011, Vol. 16 Issue 1, p46 

    Working with HIV-positive people to tell their sex and drug-injecting partners they have HIV is the first step in prevention with positives. Step 2 is encouraging positive people to consider starting antiretroviral therapy, with an eye toward reaching and maintaining an undetectable viral load....

  • Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers. McComsey, Grace A.; Tebas, Pablo; Shane, Elizabeth; Yin, Michael T.; Overton, E. Turner; Huang, Jeannie S.; Aldrovandi, Grace M.; Cardoso, Sandra W.; Santana, Jorge L.; Brown, Todd T. // Clinical Infectious Diseases;10/15/2010, Vol. 51 Issue 8, p937 

    Low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-infected subjects. Initiation of antiretroviral therapy is associated with a 2%-6% decrease in BMD over the first 2 years, a decrease that is similar in magnitude to that sustained during the first 2 years of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics